HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of thrombin-antithrombin complex contents in plasma and hematoma fluid of hypertensive intracerebral hemorrhage patients after clot removal.

AbstractBACKGROUND AND PURPOSE:
  Animal experiments indicate that the cerebral thrombin is associated with secondary brain damage after intracerebral hemorrhage (ICH). This study was aimed to investigate the concentrations of thrombin-antithrombin complex (TAT) in hematoma fluid and plasma of the patients with ICH after surgery and analyze the correlation between TAT complex levels and severity of ICH.
METHODS:
  Sixty patients with ICH were enrolled. Craniotomy for removal of intracranial blood clot was performed within 24h after ICH. Hematoma fluid and plasma were collected on postoperative days 1, 2, and 4. The plasma obtained from healthy subjects and cerebrospinal fluid from patients without cerebrovascular diseases served as controls, respectively. Enzyme-linked immunosorbent assay was used to determine the concentrations of TAT complex in the patients and controls.
RESULTS:
  TAT complex concentrations in both postoperative plasma and hematoma fluid of patients with ICH were significantly higher than those of the controls (P<0.01). In patients with ICH, hematoma fluid had a higher TAT complex level than plasma (P<0.01). The preoperative hemorrhage volume and postoperative TAT complex levels in plasma and hematoma fluid correlated positively with National Institutes of Health stroke scale and negatively with Glasgow coma score (P<0.01).
CONCLUSION:
  This study indicates that TAT complex levels of plasma and hematoma fluid correlate positively with the severity of ICH. Determination of the plasma TAT complex concentration is helpful for the evaluation of the severity of post-ICH brain injury.
AuthorsC-H Wu, R-L Yang, S-Y Huang, H-Z Li, K-Y Wang, D-H Yang, X-H Yan, X-H Xue, S-Y Wu, J-M Wang, J-S Lin, L-M Liao, L-D Chen
JournalEuropean journal of neurology (Eur J Neurol) Vol. 18 Issue 8 Pg. 1060-6 (Aug 2011) ISSN: 1468-1331 [Electronic] England
PMID21244583 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Author(s). European Journal of Neurology © 2011 EFNS.
Chemical References
  • antithrombin III-protease complex
  • Antithrombin III
  • Peptide Hydrolases
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antithrombin III (cerebrospinal fluid)
  • Female
  • Hematoma (blood, surgery)
  • Humans
  • Intracranial Hemorrhage, Hypertensive (blood, surgery)
  • Intracranial Hypertension (blood, diagnosis)
  • Male
  • Middle Aged
  • Peptide Hydrolases (blood, cerebrospinal fluid)
  • Predictive Value of Tests
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: